Delivery Order SPE2DB24D2205-SPE2DB25FEFLC
- Not listed
- The Defense Logistics Agency awarded a $26,830.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with an ultimate completion date of August 6, 2025. This competitive award, issued on August 5, 2025, carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $48,074.88 delivery order for Wezlana 90 mg/ml syringes on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $17,011.92 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price contract, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Wezlana 90 mg/ml syringes, with a contract ceiling value of $34,720.27. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $37,404.32 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This firm fixed-price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded procurement with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $12,161.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for WEZLANA 90 mg/mL syringes on July 18, 2025, with completion targeted for July 21, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will perform work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $73,246.58 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with a completion date of July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $30,488.88 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed price pricing with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,343.96 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with a completion date of August 8, 2025. This competitive award (no set-aside used) was issued on August 7, 2025, under a firm fixed price contract type. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations as a major pharmaceutical distributor supporting...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFLCDelivery Order
The Defense Logistics Agency awarded a $55,296.33 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Wezlana 90 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by July 28, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and Medical Supply Chain. The company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across diverse therapeutic domains. This delivery order for Wezlana syringes reflects the contractor's ongoing role as a critical vendor supporting military and veteran healthcare systems through the DLA's pharmaceutical acquisition programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.3k | 7/25/25 |